Brain cancer remains one of medicine's most formidable challenges, requiring sophisticated treatment approaches tailored to ...

MD-PhD student Tomer Kagan and Dr. Tal Laviv. A novel scientific method developed at Tel Aviv University promises to ...

The discovery could pave the way for a groundbreaking RNA-based multi-cancer treatment. Alternative RNA splicing functions ...

NYU scientists have discovered that cancer cells work together to withstand challenging conditions, revealing new ...

To fight this, doctors often use drugs called BRAF inhibitors, such as vemurafenib, which can stop the cancer’s growth—at ...

First patient dosed in phase 1b/2a trial for castration-resistant metastatic prostate cancer, evaluating pocenbrodib alone and with other drug combinations.

Frank J. Penedo, PhD, explains the challenges of survivorship care for patients with cancer and how he implements programs to ...

Understanding your tumor biology is key to finding the right treatment for pancreatic cancer. Identifying mutations, or changes in a [...] READ MORE ...

Dr. Sara M. Tolaney discussed HER2-positive breast cancer, highlighting key trials, evolving treatment strategies, and the ...

We recently published a list of 10 Worst High-Risk High-Reward Growth Stocks To Buy. In this article, we are going to take a ...

Veracyte VCYT underwent analysis by 5 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to ...

ZLAB’s Vyvgart revenue has been impressive, rising from roughly $93.6 million in 2024. Read more about ZLAB stock here.